Insights into the molecular features of the von Hippel-Lindau like protein
Abstract
We present an in silico characterization of the von Hippel-Lindau like protein (VLP), the only known human paralogue of the von Hippel-Lindau tumor suppressor protein (pVHL). Phylogenetic investigation showed VLP to be mostly conserved in upper mammals and specifically expressed in brain and testis. Structural analysis and molecular dynamics simulation show VLP to be very similar to pVHL three-dimensional organization and binding dynamics. In particular, conservation of elements at the protein interfaces suggests VLP to be a functional pVHL homolog potentially possessing multiple functions beyond HIF-1-dependent binding activity. Our findings show that VLP may share at least seven interactors with pVHL, suggesting novel functional roles for this under-studied human protein. These may occur at precise hypoxia levels where functional overlap with pVHL may permit a finer modulation of pVHL functions.
02 /Specification & Classification
Click any tag to browse matching papers- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Genotype-Phenotype Relations of the von Hippel-Lindau Tumor Suppressor Inferred from a Large-Scale Analysis of Disease Mutations and Interactors
G. Minervini, F. Quaglia, … S. C. E. Tosatto·bioRxiv·Aug 31, 2018
- The E3 ubiquitin-protein ligase MDM2 is a novel interactor of the von Hippel-Lindau tumor suppressor
A. Falconieri, G. Minervini, … S. C. E. Tosatto·bioRxiv·Apr 28, 2020
- VHL inhibitor binding increases intracellular level of VHL
- HNRNPC-mediated RNA processing promotes VHL-associated excessive vasculogenesis in von Hippel-Lindau syndrome revealed from patient-derived blood vessel models
Hidenori Ito, Iori Sato, … Yohei Hayashi·bioRxiv·Nov 2, 2026
- In Silico Analysis of Novel VHL Germline Mutations in Iranian RCH Patients
Masood Naseripour, Kowsar Bagherzadeh, … Fatemeh Azimi·bioRxiv·Oct 26, 2022
- Algorithmic Assessment of Missense Mutation Severity in the Von-Hippel Lindau Protein